Related Experiment Video

Updated: Sep 27, 2026

Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes
11:01

Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes

Published on: August 24, 2021

Macrophage migration inhibitory factor deficiency is associated with altered cell growth and reduced susceptibility

Oleksi Petrenko1, Gunter Fingerle-Rowson, Tina Peng

  • 1Picower Institute for Medical Research, Manhasset, New York 11030, USA.

The Journal of Biological Chemistry
|January 23, 2003
PubMed

Insights

Macrophage migration inhibitory factor (MIF) deficiency impairs cell growth and oncogenic transformation by activating E2F and p53 pathways. This suggests MIF is crucial for regulating cell proliferation and tumor development.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Macrophage migration inhibitory factor (MIF) inactivates the p53 tumor suppressor, inhibiting apoptosis and p53-responsive gene expression.
  • Understanding MIF's role in cell growth and tumor biology is critical for cancer research.

Purpose of the Study:

  • To investigate the impact of MIF deficiency on fibroblast immortalization and transformation.
  • To elucidate the role of MIF in oncogenic signaling pathways.

Main Methods:

  • Evaluation of MIF-null embryonic fibroblasts' immortalization and transformation properties.
  • Assessment of cell growth under normal and oncogene-induced conditions.
  • Analysis of Ras-mediated transformation and E2F/p53 pathway activation.

Main Results:

  • MIF-deficient fibroblasts exhibited growth impairment upon introduction of immortalizing oncogenes.
  • MIF deficiency reduced susceptibility to Ras-mediated transformation, linked to E2F activation.
  • E2F induction in MIF-null cells resulted in G(1) arrest or apoptosis, depending on p53 status.
  • Interference with p53 and E2F pathways overcame resistance to oncogenic transformation in MIF-null cells.

Conclusions:

  • MIF plays a significant role in the E2F/p53 pathway, operating downstream of Rb regulation.
  • MIF acts as a mediator in both normal and malignant cell growth processes.
  • Targeting MIF may offer therapeutic strategies for cancer by modulating cell proliferation and transformation.

More Related Videos

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion09:23

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion

Published on: October 20, 2016

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: